SPDR S&P Biotech ETF $XBI Stock Holdings Trimmed by PNC Financial Services Group Inc.

PNC Financial Services Group Inc. reduced its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 11.8% during the 1st quarter, HoldingsChannel.com reports. The fund owned 64,153 shares of the exchange traded fund’s stock after selling 8,542 shares during the quarter. PNC Financial Services Group Inc.’s holdings in SPDR S&P Biotech ETF were worth $8,194,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of the business. Avoro Capital Advisors LLC acquired a new stake in SPDR S&P Biotech ETF during the fourth quarter worth about $256,053,000. Wells Fargo & Company MN boosted its stake in SPDR S&P Biotech ETF by 75.7% in the fourth quarter. Wells Fargo & Company MN now owns 3,566,265 shares of the exchange traded fund’s stock valued at $434,835,000 after acquiring an additional 1,536,122 shares during the period. OMERS ADMINISTRATION Corp grew its holdings in shares of SPDR S&P Biotech ETF by 42,425.2% during the fourth quarter. OMERS ADMINISTRATION Corp now owns 1,190,707 shares of the exchange traded fund’s stock valued at $145,147,000 after purchasing an additional 1,187,907 shares during the last quarter. Morgan Stanley raised its position in shares of SPDR S&P Biotech ETF by 8.3% during the 4th quarter. Morgan Stanley now owns 11,491,683 shares of the exchange traded fund’s stock worth $1,401,181,000 after purchasing an additional 882,718 shares during the period. Finally, Assetmark Inc. lifted its holdings in shares of SPDR S&P Biotech ETF by 1,042,265.6% in the 4th quarter. Assetmark Inc. now owns 635,843 shares of the exchange traded fund’s stock worth $77,528,000 after purchasing an additional 635,782 shares during the last quarter.

SPDR S&P Biotech ETF Stock Performance

SPDR S&P Biotech ETF stock opened at $150.48 on Monday. The company has a 50-day simple moving average of $144.24 and a 200-day simple moving average of $133.53. The firm has a market capitalization of $10.13 billion, a P/E ratio of 11.47 and a beta of 0.82. SPDR S&P Biotech ETF has a one year low of $84.39 and a one year high of $165.71.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.